While the Botox segment is growing annually at around 20-25% in the country, Allergan India's aesthetics business is growing at 60%
The deal would involve Pfizer paying with 11.3 of its shares for each Allergan share.
Lupin Pharmaceuticals Inc, a wholly owned subsidiary of Mumbai-based Lupin Ltd, has forayed into the US pediatric segment by inking an agreement with Allergan Inc to promote 'Zymar' in that country.
The combined sales of the branded versions of the products in the US is about $3.5 billion.
'Professors can teach even when they are 90 because they don't lose their skill with words. Go deeper and there's spirituality in it.'
NPPA denies price hike on Sanofi, Novartis, and Allergan products.
Irrespective of demonetisation and GST blues, IIM Lucknow has been able to successfully place their batch of 459 students.
Amazon CEO Jeff Bezos has been ranked as the world's best performing CEO.
Asian shares dragged their feet on Tuesday.
Even as some major global pharmaceutical majors like Novartis say India's patent laws are weak and a hurdle to their investment plans for the country
Pat Welch, managing director, Allergan, was in India to promote Botox, the miracle cure for face wrinkles.
Unlike India, the US is a free-pricing market.
Top gainers from the Sensex pack are ONGC, HDFC, HUL, RIL and Cipla.
Sharp fall in capital goods production and manufacturing activity also dented sentiments.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances